Rule, Simon A. http://orcid.org/0000-0001-8937-6351
Cartron, Guillaume
Fegan, Christopher
Morschhauser, Franck
Han, Lingling
Mitra, Siddhartha
Salles, Gilles http://orcid.org/0000-0002-9541-8666
Dyer, Martin J. S.
Article History
Received: 3 April 2018
Revised: 8 November 2019
Accepted: 17 November 2019
First Online: 11 December 2019
Compliance with ethical standards
:
: S.A.R. received consulting fees from Pharmacyclics and Janssen, research funding from Janssen, honoraria from Acerta Pharma; G.C. received consulting fees from Celgene and Roche; honoraria from Celgene, Gilead Sciences, Inc, Janssen, Roche, Sanofi; C.F. received consulting fees from AbbVie, Gilead Sciences, Inc, Janssen, Roche, holds membership on Board of Directors of Roche; F.M. received consulting fees from Gilead Sciences, Inc, and Servier; honoraria from Celgene, Gilead Sciences, Inc, Janssen, BMS, Roche for scientific lectures or advisory boards; L.H. and S.M are employed by and hold stock options in Gilead Sciences, Inc; M.J.S.D. received consulting fees from AbbVie and Roche; research funding from Gilead Sciences, Inc, Ono Pharmaceuticals; honoraria from Roche. G.S. reports grants, personal fees, and non-financial support from Celgene; grants and personal fees from Roche; personal fees from Janssen, Gilead, Novartis, Amgen, Servier, BMS, Merck, MorphoSys, Acerta, Pfizer.